![Miles Congreve](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Miles Congreve
Corporate Officer/Principal bei
Nxera Pharma UK Ltd.
Profil
Miles Congreve is currently working as the Vice President-Chemistry at Heptares Therapeutics Ltd. He started this position in 2013.
Prior to his current role, he worked as a Group Leader at GSK Plc.
He also worked as a Principal at Astex Therapeutics Ltd. from 2001 to 2013.
Dr. Congreve holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leicester.
Aktive Positionen von Miles Congreve
| Unternehmen | Position | Beginn |
|---|---|---|
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Corporate Officer/Principal | 31.01.2012 |
Ehemalige bekannte Positionen von Miles Congreve
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Corporate Officer/Principal | - |
Ausbildung von Miles Congreve
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
University of Leicester
 University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
